ADD1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.383220E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.642370E-02
Normal-vs-Stage2
1.162600E-01
Normal-vs-Stage3
8.054200E-02
Normal-vs-Stage4
2.415400E-01
Stage1-vs-Stage2
4.142400E-01
Stage1-vs-Stage3
4.177000E-01
Stage1-vs-Stage4
2.990800E-01
Stage2-vs-Stage3
1.914250E-01
Stage2-vs-Stage4
6.672200E-01
Stage3-vs-Stage4
2.166200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.473010E-01
Normal-vs-AfricanAmerican
2.225200E-01
Normal-vs-Asian
1.016030E-01
Caucasian-vs-AfricanAmerican
6.237400E-01
Caucasian-vs-Asian
2.372200E-01
AfricanAmerican-vs-Asian
2.706600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.139600E-01
Normal-vs-Female
1.827370E-01
Male-vs-Female
1.975000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.482800E-01
Normal-vs-Age(41-60Yrs)
1.920780E-01
Normal-vs-Age(61-80Yrs)
1.311040E-01
Normal-vs-Age(81-100Yrs)
2.288300E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.553800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.554000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.777600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.060200E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.290300E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.645400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.291600E-01
Normal-vs-Daily Drinker
9.646300E-02
Normal-vs-Weekly Drinker
1.891560E-01
Normal-vs-Occasional Drinker
1.762210E-01
Normal-vs-Social Drinker
2.849400E-01
Non Drinker-vs-Daily Drinker
7.111200E-01
Non Drinker-vs-Weekly Drinker
6.998400E-01
Non Drinker-vs-Occasional Drinker
2.187400E-01
Non Drinker-vs-Social Drinker
3.504600E-01
Daily Drinker-vs-Weekly Drinker
9.245000E-01
Daily Drinker-vs-Occasional Drinker
3.218800E-01
Daily Drinker-vs-Social Drinker
4.938800E-01
Weekly Drinker-vs-Occasional Drinker
4.741800E-01
Weekly Drinker-vs-Social Drinker
6.334600E-01
Occasional Drinker-vs-Social Drinker
8.877000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.498000E-01
Normal-vs-Grade 2
7.786400E-01
Normal-vs-Grade 3
7.685400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.818000E-01
Grade 1-vs-Grade 3
9.984800E-01
Grade 1-vs-Grade 4
4.498000E-01
Grade 2-vs-Grade 3
7.887000E-01
Grade 2-vs-Grade 4
7.786400E-01
Grade 3-vs-Grade 4
7.685400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.489180E-01
Normal-vs-NonDiabetic
1.709760E-01
Diabetic-vs-NonDiabetic
4.894400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.116000E-01
Normal-vs-NoPancreatitis
1.422010E-01
Pancreatitis-vs-NoPancreatitis
1.946750E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.950780E-01
Normal-vs-N1
1.292650E-01
N0-vs-N1
6.795200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.591250E-01
Normal-vs-TP53-NonMutant
2.594800E-01
TP53-Mutant-vs-TP53-NonMutant
8.695000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
